Bandaram Pharma — 360° view

Bandaram Pharma, a company in the Healthcare Service Provider industry, reported revenue of ₹21 crore and net profit of ₹0.19 crore for the September 2026 quarter.

Bandaram Pharma (BSE: BANDARAM) closed at ₹18.30 on 20 Nov 2026, down 33.0% over the past year. Its market capitalisation is ₹33 crore and it trades at 131.5 times earnings.

Share price
₹18.30 (20 Nov 2026)
Market cap
₹33 Cr (20 Nov 2026)
P/E
131.54 (20 Nov 2026)
Revenue
₹21 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
4.44% (FY26)
ROE
1.42% (FY26)
Book value
₹14.9 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹49.70 / ₹17.25 (20 Nov 2026)
1-year return
-33.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: BANDARAM

Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.